Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2012 09:33 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Acquisition of NitroMist(TM) Rights Outside North America

SAN DIEGO, Feb. 3, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today the execution of a binding term sheet...
January 27, 2012 08:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Expands Commercial Oncology Offerings Through Agreement With Pediatrx for U.S. Co-Promotion of GRANISOL(R) (Granisetron) Oral Solution and AQUORAL(TM) Spray and Purchase of Non-U.S. Rights to GRANISOL(R)

SAN DIEGO and CALIFON, N.J., Jan. 27, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) and PediatRx, Inc. ("PediatRx")...
January 19, 2012 08:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Retains Argot Partners as Investor Relations Firm

SAN DIEGO, Jan. 19, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that it has retained Argot Partners, a...
January 17, 2012 10:03 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Allowance of Israeli Patent, Expanding Its Patent Portfolio for the Topical Treatment of Premature Ejaculation

SAN DIEGO, Jan. 17, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that the Israeli Patent Office...
January 10, 2012 09:51 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences and Elis Pharma Sign License Agreement for MycoVa(TM) in the Middle East and the Gulf

SAN DIEGO and DUBAI, United Arab Emirates, Jan. 10, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (www.apricusbio.com) (Nasdaq:APRI) and Elis Pharmaceuticals ("Elis")...
January 09, 2012 16:14 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Webcast Today's Presentation at Biotech Showcase(TM) 2012 in San Francisco

SAN DIEGO, Jan. 9, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chairman, President and Chief Executive Officer,...
January 09, 2012 12:28 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences and Abbott Sign Exclusive Agreement to Market Vitaros(R) (Alprostadil) in Canada

SAN DIEGO, Jan. 9, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that it has entered into an exclusive licensing...
January 04, 2012 09:49 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences CEO, Dr. Bassam Damaj, to Present at Biotech Showcase(TM) 2012 in San Francisco

SAN DIEGO, Jan. 4, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Dr. Bassam Damaj, Chairman, President and Chief...
January 03, 2012 09:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences and Stellar Pharmaceuticals Announce Exclusive License Agreement in Canada for the Commercialization of MycoVa(TM) for Onychomycosis

Apricus Bio Can Receive Up to Approximately $8 Million (Canadian) Plus Tiered Double Digit Royalties Under Multi-year Agreement Stellar Pharma Strengthens Its Dermatology Business in Canada With...
December 29, 2011 12:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Completes Acquisition of Topotarget USA, Inc.

SAN DIEGO, Dec. 29, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) announced today the closing of its acquisition of Topotarget USA, Inc.,...